Stockreport

Neurogene Announces Peer-Reviewed Publication Demonstrating Gene Therapy Candidate NGN-401 with EXACT™ Technology Regulates Transgene Expression in Preclinical Models of Rett Syndrome [Yah...

Neurogene Inc.  (NGNE) 
PDF Findings published in Science Translational Medicine NEW YORK, April 02, 2025 BUSINESS WIRE )--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to brin [Read more]